- Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung Carcinoma
-
Hwang I, Choi YL, Lee H, Hwang S, Lee B, Yang H, Chelakkot C, Han J
- KMID: 2531324
- Cancer Res Treat.
- 2022 Jul;54(3):782-792.
- doi: 10.4143/crt.2021.843
Purpose The incidence of BRAF V600E mutation in non-small cell lung carcinoma (NSCLC) is lower than 2%, which poses difficulties in finding legitimate patients for targeted therapy. We investigated the predictive... -
- CITED
-
- Close
- SHARE
-
- Close
